Introduction
============

Asymmetric dimethylarginine (ADMA) is an inhibitor of the arginine--NO pathway. ADMA accumulates when degradation in the liver by dimethylarginine dimethylaminohydrolase is impaired. In theory, plasma citrulline, formed when arginine is converted by NO synthase, and when ADMA is metabolized, would be lowered and ornithine, formed by the degradation of arginine in the urea cycle, would be potentially elevated when ADMA accumulates as in sepsis and in liver failure \[[@B1]\].

Methods
=======

Fourteen male Wistar rats were randomly allocated to lipopolysaccharide (LPS) or hemihepatectomy (HH). Plasma levels of arginine, ADMA, citrulline and ornithine were measured before and 120 minutes after 5 mg/kg LPS and HH, respectively.

Results
=======

See Table [1](#T1){ref-type="table"}.

###### 

Results

               LPS            HH                              
  ------------ -------------- ---------------- -------------- ----------------
  Arginine     151.3 ± 28.7   99.1 ± 27.9\*    138.0 ± 43.7   221.4 ± 57.1\*
  ADMA         1.14 ± 0.19    1.32 ± 0.24      0.59 ± 0.06    1.48 ± 0.27\*
  Citrulline   107.2 ± 19.3   129.1 ± 20.3\*   83.5 ± 7.36    118.4 ± 18.5\*
  Ornithine    99.8 ± 29.2    129.6 ± 39.1\*   66.4 ± 19.2    170.7 ± 50.6\*

\*Significant difference.

Conclusion
==========

Plasma levels of arginine and derivatives should not be interpreted as a reflection of metabolism at the tissue level. In HH, the elevated ADMA levels suggest dimethylarginine dimethylaminohydrolase activity depends on the liver tissue mass.
